Early-Stage

Elimination of the Capital Gains Tax For Early-Stage Investments Investors in small businesses should pay no capital gains taxes if the business is sold for a profit, so long as they keep their money at risk in those companies for at least two years.

A Funding Fix For New Businesses 2010

Elimination of the Capital Gains Tax For Early-Stage Investments Investors in small businesses should pay no capital gains taxes if the business is sold for a profit, so long as they keep their money at risk in those companies for at least two years.

A Funding Fix For New Businesses 2010

Elimination of the Capital Gains Tax For Early-Stage Investments Investors in small businesses should pay no capital gains taxes if the business is sold for a profit, so long as they keep their money at risk in those companies for at least two years.

A Funding Fix For New Businesses Walter Buckley 2010

“Surgery Choices for Women with Early-Stage Breast Cancer.” www.center4research.org/surgeryoptions.html.

The 10 Best Questions Dede Bonner 2008

“Surgery Choices for Women with Early-Stage Breast Cancer.” www.center4research.org/surgeryoptions.html.

The 10 Best Questions Dede Bonner 2008

Based on a successful Phase 2 trial, which achieved its primary endpoint of disease-free survival, the FDA granted NeuVax a Special Protocol Assessment for its Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax(TM) Treatment) study.

unknown title 2011

NeuVax(TM) (E75) makes significant progress towards initiating the Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax(TM) Treatment) study in 1H, 2012

unknown title 2011

Unlike the historical program, which targeted later-stage firms, the Startup America SBIC program will funnel funding to companies through two programs, an "Impact Investment Fund" that will match 2:1 what later-stage venture firms invest in "moderate-income areas," and "the Early-Stage Innovation Fund" that matches 1:1 early-stage investment raised by venture firms outside of Silicon Valley, Boston and New York that invest in financing rounds between $1 million and $4 million.

Forbes.com: News Maureen Farrell 2011

Galena will focus its resources on its lead product, NeuVax(TM), a cancer immunotherapy that is expected to initiate its Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) study in the first half of 2012.

unknown title 2011

Based on a successful Phase 2 trial, which achieved its primary endpoint of disease free survival (DFS), the Food and Drug Administration (FDA) granted NeuVax a Special Protocol Assessment (SPA) for its Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment) study.

unknown title 2011